Maywufa Company Ltd. (TPE:1731)
21.80
-0.10 (-0.46%)
Jan 22, 2026, 12:54 PM CST
Maywufa Company Revenue
Maywufa Company had revenue of 372.25M TWD in the quarter ending September 30, 2025, with 5.81% growth. This brings the company's revenue in the last twelve months to 1.55B, up 6.83% year-over-year. In the year 2024, Maywufa Company had annual revenue of 1.49B with 14.23% growth.
Revenue (ttm)
1.55B
Revenue Growth
+6.83%
P/S Ratio
1.88
Revenue / Employee
6.90M
Employees
224
Market Cap
2.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.49B | 185.15M | 14.23% |
| Dec 31, 2023 | 1.30B | 55.62M | 4.47% |
| Dec 31, 2022 | 1.25B | -44.11M | -3.42% |
| Dec 31, 2021 | 1.29B | 223.89M | 21.02% |
| Dec 31, 2020 | 1.07B | -35.54M | -3.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orient EuroPharma | 4.53B |
| TSH Biopharm Corporation | 1.27B |
| Allied Biotech | 821.81M |
| GeneFerm Biotechnology | 654.88M |
| Easywell Biomedicals | 588.89M |
| Johnson Chemical Pharmaceutical Works | 567.06M |
| PhytoHealth | 138.46M |
| LIWANLI Innovation | 118.93M |